Further, downstream RET‐mTORC1 signalling is found to promote AML cell growth through the suppression of autophagy and stabilization of leukaemia‐genic drivers, indicating the potential of RET as a therapeutic target in subgroups of AML patients.100. This evidence concerns the gene RET and acute myeloid leukemia.